sharp dohme llc (Merck & Co)
86
Structured Review
Merck & Co
sharp dohme llc
Sharp Dohme Llc, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dohme+llc/pmc13068445-176-11-10
Average 86 stars, based on 1 article reviews
Sharp Dohme Llc, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dohme+llc/pmc13068445-176-11-10
Average 86 stars, based on 1 article reviews
sharp dohme llc - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma Article Snippet: .. Merck Sharp and Article Title: Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma. Article Snippet: .. Merck Sharp and other:Article Title: Phase 3, Open-Label Multicenter Study of Sotatercept in Japanese Participants With Pulmonary Arterial Hypertension Article Snippet: Dr Cornell is an employee of Article Title: Exploring the Effectiveness of Imipenem/Relebactam in Patients with Antimicrobial-Resistant Hospital-Acquired Infections: Findings from Systematic Literature Reviews. Article Snippet: Funding: Funding for this research was provided by Article Title: Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma. Article Snippet: This assistance was Volume 11 ■ Issue 3 ■ 2026 https://doi.org/10.1016/j.esmoop.2026.106090 5 funded by Article Title: Cost of Illness of Metastatic Non-Small Cell Lung Cancer in Morocco: A Multicentric Retrospective Observational Study. Article Snippet: Funding/Support: This study was funded by Article Title: Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma Article Snippet: This work was supported by Article Title: Exploring the Effectiveness of Imipenem/Relebactam in Patients with Antimicrobial-Resistant Hospital-Acquired Infections: Findings from Systematic Literature Reviews. Article Snippet: Conflicts of Interest: Author Emre Yucel is an employee of |